It is especially remarkable how both compounds are capable of reducing insulin resistance by lowering glycemia and plasma insulin concentrations as well as obesity-associated inflammatory markers such as IL-6 and TNF-α. This evidence concerns the gene TNF and obesity due to melanocortin 4 receptor deficiency.